tiprankstipranks
Entera Bio Ltd (ENTX)
NASDAQ:ENTX

Entera Bio (ENTX) Financial Statements

357 Followers

Entera Bio Financial Overview

Entera Bio's market cap is currently ―. The company's EPS TTM is $-0.306; its P/E ratio is -6.46; Entera Bio is scheduled to report earnings on June 27, 2024, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue----$ 14.00K
Gross Profit----$ 6.00K
EBIT$ -2.00M$ -2.35M$ -2.33M$ -2.19M$ -3.07M
EBITDA$ -1.98M$ -2.34M$ -2.31M$ -2.18M-
Net Income Common Stockholders$ -2.00M$ -2.38M$ -2.33M$ -2.19M$ -3.04M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 11.02M$ 7.58M$ 9.13M$ 10.69M$ 12.31M
Total Assets$ 11.77M$ 8.56M$ 10.45M$ 11.61M$ 12.99M
Total Debt$ 390.00K$ 402.00K$ 456.00K$ 48.00K$ 91.00K
Net Debt$ -10.63M$ -7.18M$ -8.68M$ -10.64M$ -12.22M
Total Liabilities$ 1.38M$ 2.33M$ 2.21M$ 1.53M$ 1.37M
Stockholders Equity$ 10.39M$ 6.24M$ 8.23M$ 10.08M$ 11.75M
Cash Flow-
Free Cash Flow$ -2.62M$ -1.52M$ -1.56M$ -1.62M$ -2.01M
Operating Cash Flow$ -2.62M$ -1.52M$ -1.56M$ -1.61M$ -2.01M
Investing Cash Flow$ -5.00K-$ -1.00K$ -11.00K$ -3.00K
Financing Cash Flow$ 6.03M-$ 5.00K--
Currency in USD

Entera Bio Earnings and Revenue History

Entera Bio Debt to Assets

Entera Bio Cash Flow

Entera Bio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis